SCHEMBL5186490

SCHEMBL5186490

OCc1ccccc1O[CH]c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APOBEC3G Q9HC16 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ EPHX1 P07099 1/20 0.36
▸ PDCD1 Q15116 1/20 0.35
▸ CD274 Q9NZQ7 1/20 0.35
▸ GRIN1 Q05586 3/20 0.35
▸ GRIN2B Q13224 3/20 0.35
▸ CYP4F2 P78329 2/20 0.34
▸ CYP4A11 Q02928 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ TSHR P16473 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ PTGER4 P35408 1/20 0.33
▸ PTGER3 P43115 1/20 0.33
▸ PTGER2 P43116 1/20 0.33
▸ LMNA P02545 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3391453 0.76 APOBEC3G (0.39) APOBEC3GEPHX1PDCD1CD274CYP4F2
SCHEMBL543497 0.76 EPHX1 (0.41) APOBEC3GCYP2D6EPHX1PDCD1CD274
SCHEMBL28745945 0.73 APOBEC3G (0.36) APOBEC3GEPHX1PDCD1CD274CYP4F2
SCHEMBL30065199 0.73 APOBEC3G (0.43) APOBEC3GEPHX1PDCD1CD274CYP4F2
SCHEMBL5950358 0.72 SLC6A2 (0.50) APOBEC3GEPHX1PDCD1CD274CYP4F2
SCHEMBL6001493 0.69 NFE2L2 (0.42) SLC6A2L3MBTL1
SCHEMBL5535600 0.69 SCN4A (0.42) KDM4EMAPK1TSHR
SCHEMBL194417 0.69 HRH1 (0.60) TSHRSLC6A2SLC6A4LMNAGAA
SCHEMBL5547846 0.69 CA1 (0.56) GRIN1GRIN2BMAPK1TSHRL3MBTL1
SCHEMBL17820 0.69 IDO1 (0.57) GRIN1TSHRLMNAGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745029-A1 SUBSTITUTED MORPHOLINE COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS Warner-Lambert Company LLC (US) 2007-01-24 — — EP disclosed
WO-2005105763-A1 SUBSTITUTED MORPHOLINE COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY LLC (US) 2005-11-10 — — WO disclosed
Send feedback